🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT03747588
Recruiting Not applicable

The Comparision of Minimally-invasive and Open Pancreaticoduodenectomy for Pancreatic Cancer

NCT03747588 · tracked via the Priya Life Science China tracker
Sponsor
Peking Union Medical College Hospital
Phase
Not applicable
Started
2018-12-01
Last updated
2022-10-03

Condition(s) studied

Pancreatic CarcinomaSurgery

Investigational drug(s) / intervention(s)

Minimally-invasive pancreaticoduodenectomyOpen pancreaticoduodenectomy

Minimally-invasive pancreaticoduodenectomy: Minimally-invasive pancreaticoduodenectomy for resection of pancreatic tumor

Open pancreaticoduodenectomy: Open pancreaticoduodenectomy for resection of pancreatic tumor

Study summary

Minimally invasive pancreaticoduodenectomy remains one of the most challenging abdominal procedures. Safety and feasibility remain controversial when comparing minimally-invasive with open pancreaticoduodenectomy, especially for malignant tumors.The aim of this study was to compare minimally invasive and open pancreatoduodenectomy for short-term outcomes and long-term follow-up in a randomized trial.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * Age: \>18yr, \<75yr * Patients with pancreatic cancer or non-pancreatic cancers (biliary duct cancer or ampullary cancer) who underwent pancreatoduodenectomy * Preoperative imaging assessment is resectable or borderline resectable Exclusion Criteria: * Benign tumors of the head of pancreas * Enhanced CT diagnosis revealed that the excess of SMV was more than 180 degrees, or distant metastasis. * conversion to laparotomy because of intraoperative difficulty

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Chinese Academy of Medical Sciences & Peking Union Medical College Hospital Beijing Beijing Municipality Recruiting

More Peking Union Medical College Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03747588 on ClinicalTrials.gov ↗ ← All trials in China